The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenomics Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Genotyping
1.2.3 SNP Identification
1.2.4 Pharmacogenetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmacogenomics Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Infectious Diseases
1.3.4 Psychiatry
1.3.5 Cardiovascular
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenomics Services Market Perspective (2017-2028)
2.2 Pharmacogenomics Services Growth Trends by Region
2.2.1 Pharmacogenomics Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacogenomics Services Historic Market Size by Region (2017-2022)
2.2.3 Pharmacogenomics Services Forecasted Market Size by Region (2023-2028)
2.3 Pharmacogenomics Services Market Dynamics
2.3.1 Pharmacogenomics Services Industry Trends
2.3.2 Pharmacogenomics Services Market Drivers
2.3.3 Pharmacogenomics Services Market Challenges
2.3.4 Pharmacogenomics Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics Services Players by Revenue
3.1.1 Global Top Pharmacogenomics Services Players by Revenue (2017-2022)
3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenomics Services Revenue
3.4 Global Pharmacogenomics Services Market Concentration Ratio
3.4.1 Global Pharmacogenomics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Services Revenue in 2021
3.5 Pharmacogenomics Services Key Players Head office and Area Served
3.6 Key Players Pharmacogenomics Services Product Solution and Service
3.7 Date of Enter into Pharmacogenomics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Services Breakdown Data by Type
4.1 Global Pharmacogenomics Services Historic Market Size by Type (2017-2022)
4.2 Global Pharmacogenomics Services Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics Services Breakdown Data by Application
5.1 Global Pharmacogenomics Services Historic Market Size by Application (2017-2022)
5.2 Global Pharmacogenomics Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacogenomics Services Market Size (2017-2028)
6.2 North America Pharmacogenomics Services Market Size by Country (2017-2022)
6.3 North America Pharmacogenomics Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pharmacogenomics Services Market Size (2017-2028)
7.2 Europe Pharmacogenomics Services Market Size by Country (2017-2022)
7.3 Europe Pharmacogenomics Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics Services Market Size (2017-2028)
8.2 Asia-Pacific Pharmacogenomics Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Pharmacogenomics Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pharmacogenomics Services Market Size (2017-2028)
9.2 Latin America Pharmacogenomics Services Market Size by Country (2017-2022)
9.3 Latin America Pharmacogenomics Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics Services Market Size (2017-2028)
10.2 Middle East & Africa Pharmacogenomics Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Pharmacogenomics Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Pharmacogenomics Services Introduction
11.1.4 Abbott Laboratories Revenue in Pharmacogenomics Services Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Admera Health, LLC
11.2.1 Admera Health, LLC Company Detail
11.2.2 Admera Health, LLC Business Overview
11.2.3 Admera Health, LLC Pharmacogenomics Services Introduction
11.2.4 Admera Health, LLC Revenue in Pharmacogenomics Services Business (2017-2022)
11.2.5 Admera Health, LLC Recent Development
11.3 Mesa Laboratories, Inc.
11.3.1 Mesa Laboratories, Inc. Company Detail
11.3.2 Mesa Laboratories, Inc. Business Overview
11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Introduction
11.3.4 Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.3.5 Mesa Laboratories, Inc. Recent Development
11.4 Dynamic DNA Laboratories
11.4.1 Dynamic DNA Laboratories Company Detail
11.4.2 Dynamic DNA Laboratories Business Overview
11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Introduction
11.4.4 Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2017-2022)
11.4.5 Dynamic DNA Laboratories Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 GeneOmbio Technologies Pvt Ltd.
11.6.1 GeneOmbio Technologies Pvt Ltd. Company Detail
11.6.2 GeneOmbio Technologies Pvt Ltd. Business Overview
11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Introduction
11.6.4 GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2017-2022)
11.6.5 GeneOmbio Technologies Pvt Ltd. Recent Development
11.7 Exact Sciences Corporation
11.7.1 Exact Sciences Corporation Company Detail
11.7.2 Exact Sciences Corporation Business Overview
11.7.3 Exact Sciences Corporation Pharmacogenomics Services Introduction
11.7.4 Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2017-2022)
11.7.5 Exact Sciences Corporation Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Detail
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Pharmacogenomics Services Introduction
11.8.4 Illumina, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.8.5 Illumina, Inc. Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Detail
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2017-2022)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Detail
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 OmeCare
11.11.1 OmeCare Company Detail
11.11.2 OmeCare Business Overview
11.11.3 OmeCare Pharmacogenomics Services Introduction
11.11.4 OmeCare Revenue in Pharmacogenomics Services Business (2017-2022)
11.11.5 OmeCare Recent Development
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Detail
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Pharmacogenomics Services Introduction
11.12.4 QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2017-2022)
11.12.5 QIAGEN N.V. Recent Development
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Detail
11.13.2 Quest Diagnostics Incorporated Business Overview
11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Introduction
11.13.4 Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2017-2022)
11.13.5 Quest Diagnostics Incorporated Recent Development
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Detail
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.14.5 Thermo Fisher Scientific Inc. Recent Development
11.15 Precipio
11.15.1 Precipio Company Detail
11.15.2 Precipio Business Overview
11.15.3 Precipio Pharmacogenomics Services Introduction
11.15.4 Precipio Revenue in Pharmacogenomics Services Business (2017-2022)
11.15.5 Precipio Recent Development
11.16 23andMe, Inc.
11.16.1 23andMe, Inc. Company Detail
11.16.2 23andMe, Inc. Business Overview
11.16.3 23andMe, Inc. Pharmacogenomics Services Introduction
11.16.4 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.16.5 23andMe, Inc. Recent Development
11.17 OneOme, LLC
11.17.1 OneOme, LLC Company Detail
11.17.2 OneOme, LLC Business Overview
11.17.3 OneOme, LLC Pharmacogenomics Services Introduction
11.17.4 OneOme, LLC Revenue in Pharmacogenomics Services Business (2017-2022)
11.17.5 OneOme, LLC Recent Development
11.18 DiaCarta, Inc.
11.18.1 DiaCarta, Inc. Company Detail
11.18.2 DiaCarta, Inc. Business Overview
11.18.3 DiaCarta, Inc. Pharmacogenomics Services Introduction
11.18.4 DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.18.5 DiaCarta, Inc. Recent Development
11.19 OPKO Health
11.19.1 OPKO Health Company Detail
11.19.2 OPKO Health Business Overview
11.19.3 OPKO Health Pharmacogenomics Services Introduction
11.19.4 OPKO Health Revenue in Pharmacogenomics Services Business (2017-2022)
11.19.5 OPKO Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pharmacogenomics Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Genotyping
Table 3. Key Players of SNP Identification
Table 4. Key Players of Pharmacogenetic Testing
Table 5. Key Players of Others
Table 6. Global Pharmacogenomics Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pharmacogenomics Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Pharmacogenomics Services Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Pharmacogenomics Services Market Share by Region (2017-2022)
Table 10. Global Pharmacogenomics Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Pharmacogenomics Services Market Share by Region (2023-2028)
Table 12. Pharmacogenomics Services Market Trends
Table 13. Pharmacogenomics Services Market Drivers
Table 14. Pharmacogenomics Services Market Challenges
Table 15. Pharmacogenomics Services Market Restraints
Table 16. Global Pharmacogenomics Services Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Pharmacogenomics Services Market Share by Players (2017-2022)
Table 18. Global Top Pharmacogenomics Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2021)
Table 19. Ranking of Global Top Pharmacogenomics Services Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Pharmacogenomics Services Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacogenomics Services Product Solution and Service
Table 23. Date of Enter into Pharmacogenomics Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Pharmacogenomics Services Revenue Market Share by Type (2017-2022)
Table 27. Global Pharmacogenomics Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Pharmacogenomics Services Revenue Market Share by Type (2023-2028)
Table 29. Global Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Pharmacogenomics Services Revenue Market Share by Application (2017-2022)
Table 31. Global Pharmacogenomics Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Pharmacogenomics Services Revenue Market Share by Application (2023-2028)
Table 33. North America Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Pharmacogenomics Services Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Pharmacogenomics Services Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 43. Abbott Laboratories Company Detail
Table 44. Abbott Laboratories Business Overview
Table 45. Abbott Laboratories Pharmacogenomics Services Product
Table 46. Abbott Laboratories Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 47. Abbott Laboratories Recent Development
Table 48. Admera Health, LLC Company Detail
Table 49. Admera Health, LLC Business Overview
Table 50. Admera Health, LLC Pharmacogenomics Services Product
Table 51. Admera Health, LLC Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 52. Admera Health, LLC Recent Development
Table 53. Mesa Laboratories, Inc. Company Detail
Table 54. Mesa Laboratories, Inc. Business Overview
Table 55. Mesa Laboratories, Inc. Pharmacogenomics Services Product
Table 56. Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 57. Mesa Laboratories, Inc. Recent Development
Table 58. Dynamic DNA Laboratories Company Detail
Table 59. Dynamic DNA Laboratories Business Overview
Table 60. Dynamic DNA Laboratories Pharmacogenomics Services Product
Table 61. Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 62. Dynamic DNA Laboratories Recent Development
Table 63. F. Hoffmann-La Roche Ltd. Company Detail
Table 64. F. Hoffmann-La Roche Ltd. Business Overview
Table 65. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product
Table 66. F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 67. F. Hoffmann-La Roche Ltd. Recent Development
Table 68. GeneOmbio Technologies Pvt Ltd. Company Detail
Table 69. GeneOmbio Technologies Pvt Ltd. Business Overview
Table 70. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product
Table 71. GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 72. GeneOmbio Technologies Pvt Ltd. Recent Development
Table 73. Exact Sciences Corporation Company Detail
Table 74. Exact Sciences Corporation Business Overview
Table 75. Exact Sciences Corporation Pharmacogenomics Services Product
Table 76. Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 77. Exact Sciences Corporation Recent Development
Table 78. Illumina, Inc. Company Detail
Table 79. Illumina, Inc. Business Overview
Table 80. Illumina, Inc. Pharmacogenomics Services Product
Table 81. Illumina, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 82. Illumina, Inc. Recent Development
Table 83. Laboratory Corporation of America Holdings Company Detail
Table 84. Laboratory Corporation of America Holdings Business Overview
Table 85. Laboratory Corporation of America Holdings Pharmacogenomics Services Product
Table 86. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 87. Laboratory Corporation of America Holdings Recent Development
Table 88. Myriad Genetics, Inc. Company Detail
Table 89. Myriad Genetics, Inc. Business Overview
Table 90. Myriad Genetics, Inc. Pharmacogenomics Services Product
Table 91. Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 92. Myriad Genetics, Inc. Recent Development
Table 93. OmeCare Company Detail
Table 94. OmeCare Business Overview
Table 95. OmeCare Pharmacogenomics ServicesProduct
Table 96. OmeCare Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 97. OmeCare Recent Development
Table 98. QIAGEN N.V. Company Detail
Table 99. QIAGEN N.V. Business Overview
Table 100. QIAGEN N.V. Pharmacogenomics ServicesProduct
Table 101. QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 102. QIAGEN N.V. Recent Development
Table 103. Quest Diagnostics Incorporated Company Detail
Table 104. Quest Diagnostics Incorporated Business Overview
Table 105. Quest Diagnostics Incorporated Pharmacogenomics ServicesProduct
Table 106. Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 107. Quest Diagnostics Incorporated Recent Development
Table 108. Thermo Fisher Scientific Inc. Company Detail
Table 109. Thermo Fisher Scientific Inc. Business Overview
Table 110. Thermo Fisher Scientific Inc. Pharmacogenomics ServicesProduct
Table 111. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 112. Thermo Fisher Scientific Inc. Recent Development
Table 113. Precipio Company Detail
Table 114. Precipio Business Overview
Table 115. Precipio Pharmacogenomics ServicesProduct
Table 116. Precipio Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 117. Precipio Recent Development
Table 118. 23andMe, Inc. Company Detail
Table 119. 23andMe, Inc. Business Overview
Table 120. 23andMe, Inc. Pharmacogenomics ServicesProduct
Table 121. 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 122. 23andMe, Inc. Recent Development
Table 123. OneOme, LLC Company Detail
Table 124. OneOme, LLC Business Overview
Table 125. OneOme, LLC Pharmacogenomics ServicesProduct
Table 126. OneOme, LLC Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 127. OneOme, LLC Recent Development
Table 128. DiaCarta, Inc. Company Detail
Table 129. DiaCarta, Inc. Business Overview
Table 130. DiaCarta, Inc. Pharmacogenomics ServicesProduct
Table 131. DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 132. DiaCarta, Inc. Recent Development
Table 133. OPKO Health Company Detail
Table 134. OPKO Health Business Overview
Table 135. OPKO Health Pharmacogenomics ServicesProduct
Table 136. OPKO Health Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 137. OPKO Health Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics Services Market Share by Type: 2021 VS 2028
Figure 2. Genotyping Features
Figure 3. SNP Identification Features
Figure 4. Pharmacogenetic Testing Features
Figure 5. Others Features
Figure 6. Global Pharmacogenomics Services Market Share by Application in 2021 & 2028
Figure 7. Oncology Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Psychiatry Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacogenomics Services Report Years Considered
Figure 13. Global Pharmacogenomics Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Pharmacogenomics Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Pharmacogenomics Services Market Share by Region: 2021 VS 2028
Figure 16. Global Pharmacogenomics Services Market Share by Players in 2021
Figure 17. Global Top Pharmacogenomics Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Pharmacogenomics Services Revenue in 2021
Figure 19. North America Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Pharmacogenomics Services Market Share by Country (2017-2028)
Figure 21. United States Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Pharmacogenomics Services Market Share by Country (2017-2028)
Figure 25. Germany Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Pharmacogenomics Services Market Share by Region (2017-2028)
Figure 33. China Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Pharmacogenomics Services Market Share by Country (2017-2028)
Figure 41. Mexico Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Pharmacogenomics Services Market Share by Country (2017-2028)
Figure 45. Turkey Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 48. Admera Health, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 49. Mesa Laboratories, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 50. Dynamic DNA Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 51. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 52. GeneOmbio Technologies Pvt Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 53. Exact Sciences Corporation Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 54. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 55. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 57. OmeCare Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 58. QIAGEN N.V. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 59. Quest Diagnostics Incorporated Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 61. Precipio Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 62. 23andMe, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 63. OneOme, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 64. DiaCarta, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 65. OPKO Health Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed